The Smart Solutions expert review panel
Professor Clive Beggs PhD, CEng, FIMechE, FRSM
Clive Beggs is professor of medical technology at the University of Bradford, where he leads the Bradford Infection Group (BIG) - a multi-disciplinary research team dedicated to the prevention and control of healthcare associated infections (HCAIs). Although an engineer he has worked for many years in the field of applied microbiology and has particular expertise in the use of environmental and engineering measures to control the spread of infection in hospitals and works closely with the NHS.
David Ford
David trained in bio-engineering and led a team involved in the design of new medical and research equipment at St Mary’s Hospital, London before moving into industry to become involved in the development of complex medical devices through to volume manufacture. He has held a number of senior engineering roles in Europe and the US developing new areas of materials science. He has also held senior sales and marketing roles at companies including Vernon-Carus, where he helped the business to diversify into the provision of decontamination and infection control services to the NHS. He is currently managing director for product services with the BSI Group where his role encompasses worldwide responsibility for the ‘kitemark’. David is also a non-executive director of TrusTECH.
Professor Curtis Gemmell
Professor Curtis Gemmell is an international expert on MRSA and has considerable experience in the prevention of HCAIs. Professor Gemmell is emeritus professor of bacterial infection and epidemiology at the University of Glasgow and formerly director of the Scottish MRSA Reference Laboratory.
Andrew Jackson
Andrew began to specialise in IV care in 1995, becoming the first consultant IV nurse in the NHS in 2001. His extensive clinical role includes leading a vascular access team providing a hospital-wide vascular access service to insert a variety of vascular access devices such as peripheral cannulae, midlines and peripherally inserted central catheters, utilising specialist techniques as required. He is an honorary lecturer at Sheffield Hallam University and has advised on a number of national projects including EPIC2. Andrew has a great deal of experience evaluating innovative products and advising purchasing groups on the clinical suitability of products.
Martin Kiernan
Martin is nurse consultant in prevention and control of infection at Southport & Ormskirk NHS Trust. He has worked in infection control for 18 years.
Martin is a member of the committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI), the Department of Health (England) MRSA Improvement Programme Advisory Group and the support teams for MRSA and C. difficile improvement that advise and support healthcare organisations. Martin is currently vice-president of the Infection Prevention Society.
David Maddison
David is managing director of Maddison Ltd, a leading design and development company specialising in medical, healthcare and scientific developments. David works closely with several universities and NHS innovation hubs as mentor to their development and technology transfer process as well as providing design services to companies worldwide.
Margaret Parton
Margaret is chief executive officer of the NHS Technology Adoption Centre which is based at Central Manchester & Manchester Children's University Hospitals NHS Trust and is the first of its type in the NHS in England. Formally the UKTI life science sector champion and programme manager for the DTI UK/US bioscience collaboration, Margaret is an experienced business developer with an excellent track record in defining technology strategy, establishing partnerships and developing international project proposals. Margaret has expertise in facilitating successful collaboration with industry, NHS clinicians and managers, commissioners and procurement organisations.
Dr Neil Wigglesworth
Neil is a nurse consultant in infection control with expertise in isolation, MRSA, C. difficile and environmental contamination. He is currently the secretary of the Infection Prevention Society and an associate editor for the British Journal of Infection Control. Neil is an invited expert reviewer to the Health Technology Assessment programme, a member of the National Research Priorities Advisory Group on Healthcare Associated Infection and holds an honorary lectureship at the University of Leeds.